| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |